Psoriasis

The hardest part wasn’t the treatment. It was the trust.

Severe psoriasis is one of the most treatable serious skin conditions we see. The obstacle is rarely the medicine. It is the months lost before anyone makes a diagnosis.

Dr. Ayushman Bindal — MD Dermatology, SCE Dermatology (UK)
Consultant Dermatologist, Indore · 18 September 2026 · 7 min read

This account is shared with the patient’s permission. All identifying details have been removed or changed. It describes one person’s experience and is not a claim about what treatment will achieve for anyone else.

He walked into my clinic with his sleeves rolled down, even though it was warm outside.

When he finally showed me his skin, I understood why. Thick, red, scaly plaques covered almost his entire body: his arms, his back, his legs, his scalp. Flakes on his shirt collar. Cracks on his palms that bled when he closed his fist. He hadn’t slept properly in weeks because of the itching.

And the part that stayed with me most? This hadn’t happened overnight. For months he had been treating himself from several different sources — pills, powders, an oil suggested by a neighbour, something a relative recommended, a video online. No diagnosis had ever been made. Nobody was monitoring him. Nobody was checking whether any of it was working. And with every passing week, his psoriasis was quietly getting worse.

The real challenge

Medically, I knew what he needed. Severe psoriasis like his is a condition we understand well, and we have excellent treatments for it today.

But the hardest part of that consultation wasn’t writing a prescription. It was earning his trust.

He was scared. He had heard that “English medicines” were harsh. That they would damage his kidneys. That once you start, you can never stop. He looked at me with the kind of exhaustion that only comes from hoping something will work, again and again, and being let down each time.

So we talked. Not for five minutes, but for a long while. I explained what psoriasis actually is: not an infection, not something he caused, but an immune system that has become overactive and is attacking his own skin. I explained why his skin had kept worsening, what his options were, what the risks were, and how carefully we would monitor him at every step.

Slowly, the fear in his eyes started to soften. He agreed to begin biologic therapy, a modern, targeted treatment that calms the specific part of the immune system driving psoriasis.

One month later

When he came back for his follow-up, I almost didn’t recognise him.

Not because his skin had changed, though it had. Most of those angry plaques had faded. His palms had healed. But what struck me more was his face. He was smiling. Sleeves rolled up. Standing straighter.

He told me he had slept through the night for the first time in months. That he had worn a short-sleeved shirt to a family function. That his daughter had hugged him without him worrying about the flakes.

That is the moment every doctor lives for.

Responses to psoriasis treatment differ from person to person, and depend on the type and severity of disease, other medical conditions and the treatment chosen. No particular result can be promised to anyone.

Why I am sharing this

Psoriasis is not “just a skin problem.” It affects sleep, confidence, relationships, work and mental health. It is also linked to joint disease, heart health and metabolic conditions. It deserves proper, expert care.

Every patient has the right to choose how they want to be treated, and I respect that. But choices should be informed, and treatment should be supervised. When psoriasis is managed without a proper diagnosis or monitoring, precious time is lost, and the disease can become far more severe than it ever needed to be.

A dermatologist experienced in psoriasis doesn’t just prescribe medicine. We assess how severe the disease is, screen for related conditions, choose the right therapy for you, and walk alongside you through the journey.

If you or someone you love is living with psoriasis and feeling like nothing works, please don’t lose hope. Help exists. Relief is possible.

You don’t have to hide under long sleeves anymore.

Understanding psoriasis

Because the story above raises more questions than it answers, here is the clinical background in plain language.

What psoriasis actually is

Psoriasis is a long-term, immune-mediated disease. In healthy skin, cells take roughly a month to mature and shed. In psoriasis, immune signalling — particularly through messengers called IL-17 and IL-23 — drives skin cells to multiply in a matter of days. They pile up faster than they can be shed, producing the thickened, scaly plaques that people recognise. It is not an infection, not a result of poor hygiene, and not something a person brings on themselves.

Roughly two in every hundred people worldwide live with psoriasis. It can begin at any age, though it most often appears between the late teens and thirties, or again after fifty.

The forms it takes

• Plaque psoriasis is by far the commonest: well-defined red plaques with silvery scale, typically on elbows, knees, lower back and scalp.
• Scalp psoriasis is frequently mistaken for stubborn dandruff and is a common reason people delay seeing a dermatologist.
• Guttate psoriasis appears as small drop-like lesions, classically after a streptococcal throat infection, and is seen more often in younger patients.
• Inverse psoriasis affects skin folds — armpits, groin, under the breasts — where it looks smooth and red rather than scaly, and is often treated for months as a fungal infection.
• Nail psoriasis causes pitting, discolouration and separation of the nail from its bed. Nail involvement matters because it is associated with a higher likelihood of joint disease.
• Pustular and erythrodermic psoriasis are uncommon but serious forms that can require urgent inpatient care.

Why it is more than skin

Up to a third of people with psoriasis develop psoriatic arthritis, which can cause permanent joint damage if it is not caught early. Persistent joint pain, morning stiffness lasting more than half an hour, or a swollen finger or toe should always be mentioned to your dermatologist.

Psoriasis also carries higher rates of obesity, type 2 diabetes, high blood pressure, abnormal cholesterol, fatty liver disease and cardiovascular disease, as well as depression and anxiety. This is why a proper psoriasis consultation includes checking blood pressure, weight and metabolic parameters — not only looking at skin.

What sets it off

Psoriasis has a genetic basis, but flares are usually triggered. Common triggers include streptococcal throat infection, stress, smoking, heavy alcohol use, cold dry weather, and injury to the skin, where new lesions appear along a cut or scratch. Several medicines can provoke it, including lithium, beta-blockers, antimalarials and some anti-inflammatory drugs.

One trigger deserves particular emphasis in India, where oral steroids are widely available without prescription. Stopping systemic steroids abruptly can cause a severe rebound flare, sometimes converting stable plaque psoriasis into generalised pustular psoriasis, which is a medical emergency. Systemic steroids are generally avoided in psoriasis for precisely this reason.

How severity is judged

Severity is not simply a matter of how much skin is involved. Dermatologists assess body surface area, the thickness and redness of plaques, and crucially the effect on daily life, often using a quality-of-life score. Disease on the palms, soles, face, scalp or genitals is treated as more severe than its surface area suggests, because of the disproportionate impact on function and wellbeing.

The treatments available today

Treatment is chosen according to severity, sites involved, other medical conditions and practical considerations including cost.

• Topical treatments — corticosteroids of appropriate strength, vitamin D analogues such as calcipotriol, calcineurin inhibitors for the face and folds, coal tar, and keratolytics such as salicylic acid to lift scale. These manage limited disease well.
• Phototherapy — narrowband UVB delivered in a controlled medical setting, usually two or three sessions weekly. Effective for widespread disease and useful where systemic drugs are unsuitable. This is quite different from unmeasured sun exposure.
• Conventional systemic medicines — methotrexate, ciclosporin, acitretin and apremilast, taken orally, with periodic blood monitoring.
• Biologics — injectable treatments that block specific immune messengers such as TNF-alpha, IL-17 or IL-23. They have transformed outcomes in severe psoriasis, and require screening for tuberculosis and hepatitis before starting, with continued monitoring thereafter.

Alongside all of these, emollients used generously, weight management, stopping smoking and reducing alcohol all measurably improve disease control.

When to see a dermatologist

It is worth seeking specialist assessment if a scaly rash has persisted beyond a few weeks, if scalp flaking does not respond to ordinary anti-dandruff treatment, if plaques affect the palms, soles, face or genitals, if nails are pitting or lifting, if joints hurt or feel stiff in the mornings, or if the condition is affecting sleep, work or mood. Sudden, rapid worsening — particularly after stopping a course of steroids — needs urgent review.

Common questions about psoriasis

This article is general health information and does not replace an individual consultation, diagnosis or treatment by a qualified doctor. Treatment decisions for psoriasis depend on factors that can only be assessed in person. No treatment outcome is guaranteed. Medicines mentioned here are prescription treatments and must not be started or stopped without medical supervision.